Risk and management of congenital thrombophilia in transgender individuals undergoing gender-affirming hormone therapy.
- DOI
- 10.1080/26895269.2025.2549783
- Published
- 2026
- Container
- International journal of transgender health
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/26895269.2025.2549783,
title = {Risk and management of congenital thrombophilia in transgender individuals undergoing gender-affirming hormone therapy.},
author = {Campello E and Scala A and Bulato C and Benetti A and Faggian G and De Toni L and Simion C and Torresan F and Ferlin A and Simioni P and Garolla A and Gender Incongruence Interdisciplinary Group (GIIG)},
year = {2026},
journal = {International journal of transgender health},
doi = {10.1080/26895269.2025.2549783},
url = {https://doi.org/10.1080/26895269.2025.2549783}
}RIS
TY - JOUR TI - Risk and management of congenital thrombophilia in transgender individuals undergoing gender-affirming hormone therapy. AU - Campello E AU - Scala A AU - Bulato C AU - Benetti A AU - Faggian G AU - De Toni L AU - Simion C AU - Torresan F AU - Ferlin A AU - Simioni P AU - Garolla A AU - Gender Incongruence Interdisciplinary Group (GIIG) PY - 2026 JO - International journal of transgender health DO - 10.1080/26895269.2025.2549783 UR - https://doi.org/10.1080/26895269.2025.2549783 ER -
APA
E, C., A, S., C, B., A, B., G, F., L, D. T., C, S., F, T., A, F., P, S., A, G., & (GIIG), G. I. I. G. (2026). Risk and management of congenital thrombophilia in transgender individuals undergoing gender-affirming hormone therapy.. International journal of transgender health. https://doi.org/10.1080/26895269.2025.2549783
Source records
- pubmed · retrieved 2026-09-26T16:15:59.387Z